valcyte tablet 450 mg
dksh singapore pte. ltd. - valganciclovir - tablet, film coated - 450 mg - valganciclovir 450 mg
valcyte 450mg tablets film-coated
f. hoffmann-la roche ltd - valganciclovir (valganciclovir hydrochloride) - tablets film-coated - 450mg
valcyte
roche pharmaceuticals (israel) ltd - valganciclovir 450 mg - film coated tablets - valganciclovir - valcyte is indicated for the induction and maintenance treatment of cytomegalovirus (cmv) retinitis in patients with acquired immunodeficiency syndrome (aids). valcyte is indicated for the prevention of cmv diseasein cmv-negative patients who have received a solid organ transplant from a cmv-positive donor.
valcyte 50 mg/ml powder for oral solution
roche products limited - valganciclovir hydrochloride - powder for oral solution - 50 mg/ml - nucleosides and nucleotides excl. reverse transcriptase inhibitors
valcyte 450 milligram film coated tablet
pco manufacturing - valganciclovir - film coated tablet - 450 milligram - nucleosides and nucleotides excl. reverse transcriptase inhibitors
valcyte 450 milligram film coated tablet
roche products limited - valganciclovir - film coated tablet - 450 milligram - nucleosides and nucleotides excl. reverse transcriptase inhibitors
valcyte 450mg film-coated tablets
roche products limited 6 falcon way, shire park, welwyn garden city, al7 1tw, united kingdom - valganciclovir - film-coated tablet - valganciclovir 450 mg - antivirals for systemic use
valcyte 50mg/ml powder for oral solution
roche products limited 6 falcon way, shire park, welwyn garden city, al7 1tw, united kingdom - valganciclovir - powder for oral solution - valganciclovir 50 mg/ml - antivirals for systemic use
valganciclovir
aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - valganciclovir - film-coated tablet - valganciclovir 450 mg - antivirals for systemic use
valganciclovir 450mg film-coated tablets
milpharm limited - valganciclovir - film-coated tablets - 450mg - antivirals for systemic use, nucleosides and nucleotides excl. reverse transcriptase inhibitors - it is indicated for the induction and maintenance treatment of cytomegalovirus (cmv) retinitis in adult patients with acquired immunodeficiency syndrome (aids) and for the prevention of cmv disease in cmvnegative adults and children (aged from birth to 18 years) who have received a solid organ transplant from a cmv-positive donor.